You searched for "Breathing"
In conversation with Joana Araújo – Chair of the ESPO Junior Board
In the lead-up to the ESPO (European Society of Pediatric Otorhinolaryngology) Virtual Conference on 20 Feb 2021, Ray Clarke (President, ESPO 2023) interviewed Joana Araújo (Chair, ESPO Juniors Board) to find out a bit more about ESPO Juniors and their...
Inner ear immunity
There is much speculation regarding the ear’s immune response. The environment in which we live and breathe is getting ever more complex; aspects such as the percentage of the population with autoimmune conditions are on the rise and, therefore, it...How to deliver bad news better
Delivering bad news well takes experience and time. The Ida team recommend the SPIKES protocol; providing structure for relaying bad news, giving confidence to those delivering it, and leaving recipients feeling cared for and informed. It’s among the most distressing...First UK hypoglossal nerve stimulation implant in the treatment for moderate to severe OSA
Obstructive sleep apnoea has been treated in many different ways over the years. We hear from Yakubu Karagama about one of the latest surgical developments. Introduction Obstructive sleep apnoea (OSA) is by far the most common sleep disorder, affecting all...First ever WHO World Report on Hearing launched on 3 March
On 3 March, thousands of people in over 100 countries joined together to celebrate World Hearing Day and to work together towards patient-centred ear and hearing care for all. This day also marked the historic launch of the first ever...
A ‘smarter’ personal amplification device
The hearing aids available on the market today are undeniably impressive, particularly when compared to their clunky and squeaky predecessors. At a most basic level, hearing aids sample the surrounding auditory signal in real-time, breaking sounds down into frequency-specific channels....Inspired by Ida: In conversation with Lise Lotte Bundesen, Managing Director of the Ida Institute
The Ida Institue takes a collaborative approach to developing tools and resources that can be used by clinicians around the world to improve person-centred care. Their Managing Director Lise Lotte Bundesen tells us about their newest project, Inspired by Ida,...
Can we predict how much benefit patients will get from ESS with a novel monoclonal antibody
Mepolizumab (Nucala) is a humanised IgG1 monoclonal antibody that acts as an IL-5 antagonist. It has been shown to be highly effective in treating severe asthma. It is hypothesised that it will be effective for patients with recalcitrant CRSwNP. This...
